Anti-MEF2A antibody [EP1706Y]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
5
(2 Reviews)
|
(14 Publications)
Rabbit Recombinant Monoclonal MEF2A antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 14 publications.
View Alternative Names
MEF2, MEF2A, Myocyte-specific enhancer factor 2A, Serum response factor-like protein 1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-MEF2A antibody [EP1706Y] (AB76063)
Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling MEF2A with purified ab76063 at 1/40 dilution (10 μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-MEF2A antibody [EP1706Y] (AB76063)
Immunocytochemistry/ Immunofluorescence analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling MEF2A with Purified ab76063 at 1 : 100 dilution (4.3 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor®594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor®488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-MEF2A antibody [EP1706Y] (AB76063)
Overlay histogram showing MCF-7 cells stained with unpurified ab76063 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76063, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in MCF-7 cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
- WB
Unknown
Western blot - Anti-MEF2A antibody [EP1706Y] (AB76063)
The observed band size may be different from the predicted molecular weight as the protein is sumoylated.
All lanes:
Western blot - Anti-MEF2A antibody [EP1706Y] (ab76063) at 1/10000 dilution
Lane 1:
Fetal brain lysate at 10 µg
Lane 2:
Human heart lysate at 10 µg
Lane 3:
HeLa lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 55 kDa
Observed band size: 70 kDa
false
- WB
Unknown
Western blot - Anti-MEF2A antibody [EP1706Y] (AB76063)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MEF2A antibody [EP1706Y] (ab76063) at 0.2 µg/mL
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Lane 2:
3T3-L1 (Mouse embryonic fibroblast) whole cell lysates at 15 µg
Lane 3:
Mouse brain lysates at 15 µg
Lane 4:
Rat brain lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 55 kDa
Observed band size: 66 kDa
false
- WB
AbReview50854****
Western blot - Anti-MEF2A antibody [EP1706Y] (AB76063)
Lanes from left to right : cropped MW marker ladder, 1, 2, 3, 4.
Blocking was performed with 5% milk for 1 hour at room temperature.
All lanes:
Western blot - Anti-MEF2A antibody [EP1706Y] (ab76063) at 1/1000 dilution
All lanes:
Murine cardiomyocyte whole cell lysate at 25 µg
Secondary
All lanes:
Goat anti-rabbit polyclonal HRP conjugate.
Predicted band size: 55 kDa
false
Exposure time: 30s
Image is courtesy of an anonymous AbReview.
Related conjugates and formulations (7)
-
Anti-MEF2A antibody [EP1706Y] - BSA and Azide free
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-MEF2A antibody [EP1706Y]
-
660 APC
APC Anti-MEF2A antibody [EP1706Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-MEF2A antibody [EP1706Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-MEF2A antibody [EP1706Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-MEF2A antibody [EP1706Y]
-
578 PE
PE Anti-MEF2A antibody [EP1706Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MEF2A participates in transcriptional regulation as part of a larger complex that includes other regulatory proteins. This transcription factor plays an essential role in the development and function of muscles. It activates the transcription of genes necessary for muscle fiber formation and adaptation. MEF2A also influences the expression of genes related to neuronal survival and plasticity impacting cognitive function and memory in the brain.
Pathways
MEF2A is involved in both the MAPK/ERK and PI3K/Akt pathways which are significant for cellular growth survival and differentiation. MEF2A interacts with proteins like MAPK and PI3K impacting these signaling pathways that regulate cell proliferation and apoptosis. This interaction highlights its role in cellular response to external stimuli and stress signals positioning MEF2A as an important factor in cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Chemical biology & drug design 105:e70113 PubMed40317895
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular biology letters 29:154 PubMed39695937
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of pineal research 76:e70010 PubMed39618344
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 65: PubMed39329212
2024
Applications
Unspecified application
Species
Unspecified reactive species
Genome biology 24:248 PubMed37904237
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:8904 PubMed37264030
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in veterinary science 9:853819 PubMed35692290
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science translational medicine 13:eabd7695 PubMed34731014
2021
Applications
Unspecified application
Species
Unspecified reactive species
Immunity 54:1665-1682.e14 PubMed34129840
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neuroscience 15:641345 PubMed33584197
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com